Literature DB >> 35393630

A Case of Apocrine Carcinoma Arising in a Sebaceous Naevus: Detection of HRAS G13R Mutation.

Shiho Katsuie, Yukiko Kiniwa1, Asuka Mikoshiba, Keisuke Goto, Ryuhei Okuyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35393630      PMCID： PMC9574673          DOI： 10.2340/actadv.v102.2034

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  5 in total

1.  Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.

Authors:  Leopold Groesser; Eva Herschberger; Arno Ruetten; Claudia Ruivenkamp; Enrico Lopriore; Markus Zutt; Thomas Langmann; Sebastian Singer; Laura Klingseisen; Wulf Schneider-Brachert; Agusti Toll; Francisco X Real; Michael Landthaler; Christian Hafner
Journal:  Nat Genet       Date:  2012-06-10       Impact factor: 38.330

2.  Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.

Authors:  Trine Tramm; Jee-Yeon Kim; Fattaneh A Tavassoli
Journal:  Am J Surg Pathol       Date:  2011-02       Impact factor: 6.394

3.  Genetic analyses of a secondary poroma and trichoblastoma in a HRAS-mutated sebaceous nevus.

Authors:  Tomoyuki Minowa; Takafumi Kamiya; Tokimasa Hida; Masae Okura; Junji Kato; Masashi Idogawa; Shoichiro Tange; Tomomi Hirano; Takashi Tokino; Hisashi Uhara
Journal:  J Dermatol       Date:  2021-04-27       Impact factor: 4.005

4.  Secondary neoplasms associated with nevus sebaceus of Jadassohn: a study of 707 cases.

Authors:  Munir H Idriss; Dirk M Elston
Journal:  J Am Acad Dermatol       Date:  2013-11-20       Impact factor: 11.527

5.  Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus.

Authors:  Jonathan L Levinsohn; Li C Tian; Lynn M Boyden; Jennifer M McNiff; Deepak Narayan; Erin S Loring; Duri Yun; Jeffrey L Sugarman; John D Overton; Shrikant M Mane; Richard P Lifton; Amy S Paller; Annette M Wagner; Richard J Antaya; Keith A Choate
Journal:  J Invest Dermatol       Date:  2012-10-25       Impact factor: 8.551
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.